» Articles » PMID: 36290771

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

Overview
Date 2022 Oct 27
PMID 36290771
Authors
Affiliations
Soon will be listed here.
Abstract

In the last few decades, endocannabinoids, plant-derived cannabinoids and synthetic cannabinoids have received growing interest as treatment options in neurodegenerative conditions. In various experimental settings, they have displayed antioxidative, anti-inflammatory, antiapoptotic, immunomodulatory, and neuroprotective effects. However, due to numerous targets and downstream effectors of their action, the cellular and molecular mechanisms underlying these effects are rather complex and still under discussion. Cannabinoids are able to neutralize free radicals and modulate the production of reactive oxygen species and the activity of antioxidative systems acting on CB1 and CB2 cannabinoid receptors. The activation of CB1 receptors stimulates signaling pathways involved in antioxidative defense and survival (such as the phosphoinositide 3-kinase (PI3K)/Akt, mitogen-activated protein kinase (MAPK), and Nrf2 pathways) and regulates glutamatergic signaling, the activation of N-methyl-D-aspartate (NMDA) receptors, calcium influx, and the induction of Ca-regulated signaling cascades, whereas the neuroprotective effects mediated by CB2 receptors are due to the suppression of microglial activation and the release of prooxidative and proinflammatory mediators. This review summarizes the main molecular mechanisms and new advances in understanding the antioxidative and neuroprotective effects of cannabinoids. Because of the plethora of possible pharmacological interventions related to oxidative stress and cannabinoid-mediated neuroprotection, future research should be directed towards a better understanding of the interplay between activated signal transduction pathways and molecular targets with the aim to improve treatment options and efficacy by targeting the endocannabinoid system.

Citing Articles

Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer.

Lamtha T, Jongkon N, Lertvanithphol T, Horprathum M, Seetaha S, Choowongkomon K ACS Omega. 2025; 10(6):6191-6200.

PMID: 39989803 PMC: 11840771. DOI: 10.1021/acsomega.4c11108.


Evaluation of the Efficacy of a Full-Spectrum Low-THC Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity.

Ross-Munro E, Isikgel E, Fleiss B Biomolecules. 2024; 14(11).

PMID: 39595610 PMC: 11592195. DOI: 10.3390/biom14111434.


Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection.

Jazvinscak Jembrek M Antioxidants (Basel). 2024; 13(9).

PMID: 39334692 PMC: 11428803. DOI: 10.3390/antiox13091033.


Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment.

Mattar M, Umutoni F, Hassan M, Wamburu M, Turner R, Patton J Life (Basel). 2024; 14(8).

PMID: 39202733 PMC: 11355765. DOI: 10.3390/life14080991.


Interplay among Oxidative Stress, Autophagy, and the Endocannabinoid System in Neurodegenerative Diseases: Role of the Nrf2- p62/SQSTM1 Pathway and Nutraceutical Activation.

Armeli F, Mengoni B, Laskin D, Businaro R Curr Issues Mol Biol. 2024; 46(7):6868-6884.

PMID: 39057052 PMC: 11276139. DOI: 10.3390/cimb46070410.


References
1.
Zhou Y, Yang L, Ma A, Zhang X, Li W, Yang W . Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. Neuropharmacology. 2012; 63(2):242-9. DOI: 10.1016/j.neuropharm.2012.03.008. View

2.
Lastres-Becker I, Cebeira M, de Ceballos M, Zeng B, Jenner P, Ramos J . Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci. 2002; 14(11):1827-32. DOI: 10.1046/j.0953-816x.2001.01812.x. View

3.
Nadal X, Del Rio C, Casano S, Palomares B, Ferreiro-Vera C, Navarrete C . Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. Br J Pharmacol. 2017; 174(23):4263-4276. PMC: 5731255. DOI: 10.1111/bph.14019. View

4.
Xu Z, Lv X, Dai Q, Ge Y, Xu J . Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it's role in metabolic defects and neuronal apoptosis after TBI. Mol Brain. 2016; 9(1):75. PMC: 4971620. DOI: 10.1186/s13041-016-0257-8. View

5.
Derkinderen P, Valjent E, Toutant M, Corvol J, Enslen H, Ledent C . Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci. 2003; 23(6):2371-82. PMC: 6742049. View